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SUMMARY
This study examined the prevalence of HIV and other sexually transmitted infections (STIs) in
pregnant women in Kinshasa, the Democratic Republic of the Congo (DRC). Between April and
July 2004, antenatal attendees at two of the largest maternity clinics in Kinshasa were tested to
identify HIV status, syphilis, Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). HIV
seroprevalence was 1.9% in 2082 women. With PCR techniques, CT and NG infections were also
uncommon in the first 529 women (1.7% and 0.4%, respectively). No active syphilis infection
case was identified by Treponema pallidum haemagglutination assay (TPHA) and rapid plasma
reagin test (RPR). A woman’s risk of HIV infection was significantly associated with her
reporting a male partner having had other female sexual partners (OR 2.7, 95% CI 1.2–6.2).
The continuing low seroprevalence of HIV in pregnant women from Kinshasa was confirmed.
Understanding factors associated with this phenomenon could help prevent a future HIV
epidemic in low HIV transmission areas in Africa.
INTRODUCTION
About 25.8 million HIV-seropositive individuals live
in sub-Saharan Africa, representing two thirds of the
world’s total HIV burden [1]. HIV and other sexually
transmitted infections (STIs) are the second most
common cause of healthy life years lost in women
aged 15–44 years in Africa, and account for 17% of
the total disease burden in this population [2]. Despite
the notable endemicity of HIV in sub-Saharan Africa,
HIV seroprevalence in pregnant women differs
markedly across this region, ranging from a low of
1% in Senegal and Mauritania to a high of 39% in
Swaziland [3].
Time trends of HIV seropositivity in pregnant wo-
men have been used to monitor the HIV epidemic at
the population level [4]. Although little data are
available on HIV seroprevalence in many Central
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African countries, HIV seroprevalence data in the
Democratic Republic of the Congo (DRC) have
been documented since 1984 by the National AIDS
Control Programme and Project SIDA, the first in-
ternational HIV/AIDS programme in sub-Saharan
Africa. Taken together, HIV prevalence in pregnant
women in the DRC has consistently remained at
<10% [5–8]. Most recently, HIV prevalence in preg-
nant women in the capital city Kinshasa has been
stable, no more than 5% between 2000–2004 [9–12].
Data in 2002 for 1267 pregnant women from four
major cities in the DRC reported a HIV-1 seroposi-
tivity of 3.5% [11]. Official sentinel survey data for
2003–2004 showed that the HIV-1 seroprevalence in
pregnant women in the DRC was 4.5% [12].
In this report, we document the prevalence and
associated risk factors of HIV infection and selected
STIs in a large representative sample of pregnant
women from two major maternity clinics in Kinshasa
in 2004.
METHODS
Between April and July 2004, 2138 consecutive ante-
natal clinic attendees at the Kingasani and Binza
maternity clinics in Kinshasa, DRC were invited
to participate in a prevalence survey of HIV and
selected STIs in order to plan future studies of infec-
tion control in pregnant women. Inclusion criteria
for participation were: >15 years of age, agreement
to participate in HIV testing, and receipt of no pre-
vious antenatal care (ANC) during their current
pregnancy. A total of 2134 women (99.8%) were
eligible and 33 women (1.6%) declined to participate.
Informed consent was obtained from each partici-
pant, including parental consent from participating
minors. All 2101 consenting participants underwent
HIV testing, provided a 5 ml blood specimen, and
were individually interviewed by trained female
nurses on sociodemographic information, previous
pregnancy history, and sexual behaviour. In this
study, for history of previous birth outcomes, we
defined neonatal, infant, and child deaths as deaths
<1 month of birth, deaths between 1 month and
1 year of birth, and deaths >1 year of birth, respect-
ively. Limited resources enabled the provision of
STI screening for only the first consenting 529
women. Among these women, vaginal swab
samples (Starswab II with liquid Stuart’s medium,
Starplex Scientific, Entobicoke, ON, Canada) were
successfully collected by trained female nurses from
524 women at the time of a speculum pelvic examin-
ation.
Blood samples were transported on a daily basis
to the National AIDS Reference Laboratory in
Kinshasa where plasma was separated and then fro-
zen at x20 xC. The frozen blood plasma samples
were tested for HIV and syphilis within 48 h. HIV-
1/-2 serostatus was first tested using two different
enzyme-linked immunosorbent assays (ELISAs):
Vironostika1 HIV Uni-Form II Plus 0 (bioMérieux,
Boxtel, The Netherlands) and Enzygnost1 Anti-HIV
½ Plus (Dade Behring, Marburg, Germany). If both
tests were positive, HIV seropositivity was confirmed
with a rapid test assay (Determine HIV-1/-2; Abbott
Laboratory, Tokyo, Japan). All women with two
positive ELISAs and a positive rapid test result were
classified as being HIV positive. Eleven women with
indeterminate HIV results (0.5%) and eight with
missing samples were excluded from data analyses,
leaving a total of 2082 women.
Using residual blood specimens, syphilis sero-
positivity was determined by a rapid plasma reagin
test (RPR: Human GmbH, Wiesbaden, Germany)
and a Treponema pallidum haemagglutination assay
(TPHA: Serodia1-TP-PA; Fujirebio Inc., Tokyo,
Japan) with 525 women. Samples testing positive for
RPR or TPHA and 2% of randomly selected negative
samples were shipped to the laboratory at the
University of North Carolina at Chapel Hill (UNC-
CH) for quality control.
Vaginal swab samples were tested for Chlamydia
trachomatis (CT) and Neisseria gonorrhoeae (NG)
DNA using an amplicor polymerase chain reaction-
based assay (PCR, Roche Diagnostics, Indianapolis,
IN, USA) at the UNC-CH microbiology laboratory.
All positive samples were systematically re-tested
for confirmatory purposes. To monitor the adequacy
of specimen storage and transport conditions, a vial
of Accurun 341 external positive control (BBI
Diagnostics, West Bridgewater, MA, USA) con-
taining CT and NG intact organisms was stored
and included with each batch of specimens shipped
from Kinshasa to UNC-CH. All vials tested positive
in the Amplicor CT/NG assay, confirming that
specimen storage and transport conditions had been
adequate.
To identify risk factors for HIV seropositivity, odds
ratios (ORs) and corresponding 95% confidence in-
tervals (CIs) were calculated using multivariate logis-
tic regression adjusting for maternal age [13, 14] and
site of ANC. For sparse data (cell counts with sample
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size f5), exact logistic regression was performed
using LogXact 4 for Windows (Cytel Software
Corporation, Cambridge, MA, USA).
The protocol was approved by the Institutional
Review Boards at UNC-CH, RTI International, and
the Kinshasa School of Public Health.
RESULTS
We detected a HIV prevalence rate of 1.9% (95% CI
1.3–2.5) in the 2082 participating pregnant women
whose mean age was 27.3 years (range 15–45 years)
(Table 1). HIV seropositivity was low in women from
both antenatal clinics (1.6% in Kingasani and 2.2%
in Binza, P=0.33), and in the first 529 women who
consented to have STI testing (1.5%) (data not
shown). No active syphilis case was detected in 525
women. Three samples (0.6%) were RPR positive but
TPHA negative, suggesting false-positive results.
External quality control of the syphilis test performed
at the UNC-CH laboratory confirmed these results.
CT and NG infection prevalence rates were 1.7%
and 0.4%, respectively in 521 women. None of the
patients were found to have more than one STI.
No significant association was found between wo-
men’s age and HIV prevalence (Table 2). Women
aged between 25 and 29 years had a slightly higher
HIV risk, with the lowest prevalence in the youngest
and the oldest women, although these differences were
not statistically significant. A woman’s HIV risk was
significantly associated with her reporting a male
partner as having had other female sexual partners
(OR 2.7, 95% CI 1.2–6.2), although only a small pro-
portion of women (10.4%) reported this behaviour. A
pregnant woman’s reported history of previous neo-
natal deaths was not related to her risk of HIV infec-
tion; however, a history of previous infant (OR 2.5,
95% CI 1.1–5.6) and child (OR 2.7, 95% CI 1.2–5.9)
deaths were positively associated with HIV infection.
When the statistically significant factorsweremodelled
simultaneously, a woman’s report of a male partner
having ever had other female sexual partner(s), infant
deaths, and child deaths remained significant.
DISCUSSION
This study confirms the continuing paradoxically low
HIV seroprevalence in Kinshasa, DRC, a location
where many of the factors found to enable HIV infec-
tion in other regions of sub-Saharan Africa are highly
prevalent [7, 8]. These enablers include political and
social instability, widespread poverty, long-lasting
conflicts in the Eastern parts of the country, com-
mercial sex and lack of access to effective testing and
treatment of STIs. Despite these highly prevalent en-
abling conditions, the persistently stable and low HIV
prevalence rates remain a striking and unexplained
phenomenon.
The HIV prevalence rate in our study participants
(1.9%) was consistent with the results from the
Global AIDS Programme in Kinshasa that docu-
mented a 1.9% HIV-1 seroprevalence in 38 603
pregnant women surveyed at 21 maternity clinics
(excluding Kingasani and Binza clinics) from 2004
to July 2005 (F. Behets, personal communication).
The cumulative HIV prevalence at the Kingasani
and Binza maternity clinics from 2003 to 2005 was
2.4% among 37988 pregnant women (R. Matendo,
personal communication). Similarly low HIV sero-
prevalence rates were reported in pregnant women in
neighbouring countries in 2001–2002 including
Angola (2%) and the Republic of the Congo (4%) [3],
although high HIV prevalence rates have been re-
ported in nearby Zambia (23.5%) [10] and the Central
African Republic (CAR; 15%) [3].
Our study provides new data on the burden of
selected STIs (CT and NG) in pregnant women from
the DRC using sensitive PCR-based laboratory
testing. Antenatal attendees from the two largest
maternity clinics in Kinshasa had a low prevalence
of both infections (1.7% and 0.4%, respectively). A
previous study in Kinshasa [15] found a higher
prevalence of CT (5.2%) and NG (1.6%) infections in
Table 1. Prevalence of HIV and selected sexually
transmitted infections in female antenatal clinic
attendees at two maternity clinics in Kinshasa,





HIV 2082 40 (1.9)
Syphilis
Past/treated infection# 525 12 (2.3)
Active infection$ 525 0 (0.0)
Chlamydia trachomatis 521 9 (1.7)
Neisseria gonorrhoeae 521 2 (0.4)
* Numbers may differ due to missing samples and refusals.
# Defined as Treponema pallidum haemagglutination
assay (TPHA) positive and rapid plasma reagin test (RPR)
negative.
$ Defined as TPHA and RPR positive.
1292 R. Kinoshita-Moleka and others
Table 2. Risk factors for HIV infection in 2082 female antenatal clinic attendees at two maternity clinics in







Site of maternity clinics
Binza 1039 23 (2.2) 1.3 (0.7–2.5)
Kingasani 1043 17 (1.6) 1#
Sociodemographic characteristics
Age (years)·
<20 213 2 (0.9) 0.9 (0.1–8.4)
20–24 538 8 (1.5) 1.5 (0.3–8.7)
25–29 609 18 (3.0) 2.9 (0.8–15.5)
30–34 437 9 (2.1) 2.0 (0.5–11.4)
o35 285 3 (1.1) 1#
P value for linear trend 0.83
P value (2 D.F.) for quadratic trendk 0.19
Marital status·
Married 1754 35 (2.0) 1#
Cohabiting 288 3 (1.0) 0.7 (0.1–2.5)
Single 37 2 (5.4) 4.0 (0.4–19.4)
Sexual behaviour
Woman reports male sexual partner
has had other female partner(s)
Never 1479 22 (1.5) 1#
Ever 216 8 (3.7) 2.7 (1.2–6.2)$
Unsure 383 10 (2.6) 1.9 (0.9–4.0)
More than one sexual partner
3 months prior to the pregnancy·
No 2056 39 (1.9) 1#
Yes 23 1 (4.4) 2.8 (0.1–19.2)
Previous obstetric/birth outcomes
Live children
0 563 9 (1.6) 1#
1 446 12 (2.7) 1.3 (0.5–3.3)
2–3 627 13 (2.1) 0.9 (0.3–2.3)
o4 446 6 (1.4) 0.7 (0.2–2.4)
P value for linear trend 0.26
History of infant/child deaths
Neonatal deaths (<1 month of birth)·
Never 1955 38 (1.9) 1#
Ever 127 2 (1.6) 0.8 (0.1–3.2)
Infant deaths (1 month to 1 year of birth)
Never 1885 32 (1.7) 1#
Ever 197 8 (4.1) 2.5 (1.1–5.6)$
Child deaths (>1 year of birth)
Never 1850 31 (1.7) 1#
Ever 232 9 (3.9) 2.7 (1.2–5.9)$
CI, Confidence interval ; OR, odds ratio.
* Adjusted for age and site of antenatal clinic.
# Reference category.
$ P<0.05.
· Data analysed by exact logistic regression.
k Standard logistic regression result.
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1160 pregnant women using an enzyme immunoassay
and cultured endocervical smears, respectively. The
low prevalence of cervical infections found in our
present study appears to be real, given the higher
sensitivity of the PCR-based laboratory assay used.
In our study, no active syphilis was found and only
0.6% of women screened tested RPR positive, TPHA
negative. These later results are consistent with the
low syphilis prevalence rate of 0.43% by RPR only
found in 1619 female antenatal clinic attendees from
three maternity clinics in Kinshasa in 2003 [16].
A woman’s risk of HIV infection was significantly
associated with her reporting a male partner as having
had other female sexual partners. These data are
consistent with population-based studies from
Nigeria showing a higher risk of STIs in women re-
porting a partner with higher risk sexual behaviour
[13, 17]. Given the low HIV seroprevalence reported
here, sexual network analyses documenting the extent
of partner change and of concurrent sexual partner-
ships in this population may provide further insights
[18].
Civil war, political instability, and widespread
poverty in the DRC could have been expected to
increase the vulnerability of the population to HIV
and other STI infections, yet the prevalences of HIV
and selected STIs reported here were low. HIV
acquisition and transmission can be facilitated by
other STI infections through multiple immunological
and biological pathways [19–21]. The low prevalence
of selected STIs found here may provide one potential
explanation for the stable, low HIV seroprevalence
in the DRC relative to other sub-Saharan African
countries. Behavioural factors including a high prev-
alence of male circumcision have been shown to sig-
nificantly reduce HIV risk [22, 23]. The circumcision
rate is estimated to be 80–90% in Congolese males in
Kinshasa (B. Lapika, personal communication). The
low and stable HIV prevalence in the DRC might also
be attributable to high HIV-related mortality that
could have maintained the balance between the
number of new infections cases and HIV deaths [7].
A better access to quality health care could contribute
to prolongation of life in people living with HIV/
AIDS, and hence a longer duration of HIV infection
in HIV positives and high levels of HIV prevalence in
a population [24]. However, in the DRC this is not the
case, due to the rapidly deteriorating health service
system and lack of access to health care as a conse-
quence of decades of mismanagement and corruption,
and extreme poverty [11].
Finally, the extremely high diversity of HIV-1 sub-
types found in the DRC may be associated with the
relatively slow HIV transmission patterns compared
to other sub-Saharan African countries with high
prevalence where only one HIV-1 subtype (subtype C)
is predominant [25, 26]. As observed in the DRC, the
largest variety of HIV-1 subtypes is found in Central
Africa where the HIV prevalence has been low except
in CAR (15%) and Cameroon (8%) (data for
ANC attendees) [3]. Interestingly, subtype E which is
primarily responsible for the explosion of the HIV
epidemic in the heterosexual population in Thailand,
is commonly found in CAR but not in other African
countries [26]. Further studies are required to identify
biological differences in infectivity, transmissibility,
and immunogenicity among these HIV-1 subtypes
that may explain trends in HIV seroprevalence in
countries such as DRC [27, 28].
Our study results are based on a large sample size
and sensitive laboratory PCR techniques for the
ascertainment of selected STIs. Furthermore, HIV
seroprevalence was determined at two of the largest
maternity clinics where 14.2% of the 114 144 deliver-
ies occur in Kinshasa (Office of District Medical
Inspection, Kinshasa, DRC). An estimated 85% of
pregnant women attend at least one ANC visit during
pregnancy in Kinshasa [29].
Nevertheless, our study has certain limitations.
Despite the large number of women enrolled in
the study, the sample size was too small to examine
the association between HIV and other STIs [19–21],
due to the low prevalence of both HIV and selected
STIs. Selecting only twomaternity clinics may not rep-
resent the pregnant population from different socio-
demographic and geographical areas in Kinshasa.
Data on other important behavioural risk factors for
HIV and STI infections such as condom use, number
of current or lifetime male sexual partners, and the
prevalence of sex work in the target population
were not available as this was beyond the scope of the
study.
The historically stable and low seroprevalence of
HIV in pregnant women was confirmed at two of the
largest maternity clinics in Kinshasa, DRC. The
prevalence rates of CT, NG, and syphilis were also
lower than expected in this population. Understand-
ing the factors contributing to the low and stable HIV
prevalence in the DRC, including further analyses
of the balance between HIV/AIDS deaths and newly
infected cases, patterns of sexual behaviours, and
the prevalence of other STIs such as herpes simplex
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virus 2 (HSV-2) are important to prevent the possible
future expansion of an HIV epidemic in the low HIV
transmission areas in Africa.
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